As investors look for undervalued assets amidst the broader market uncertainty, penny stocks offer potential opportunities for high-risk, high-reward plays. While these volatile, low-priced names are best suited for investors with a healthy appetite for risk, buying and holding high-quality penny stocks over the long haul can result in outsized gains for patient investors.
AbCellera Biologics (ABCL), a niche player in the biotech industry, is one name worth keeping on your penny stock watchlist after the company's CEO scooped up shares through his holding company. Additionally, this low-dollar stock has some deep-pocketed fans, as billionaires have also diversified their portfolios by investing in AbCellera Biologics. With big money placing their best on the biotech, it's a significant vote of confidence in the company's long-term growth prospects.
